Drug Trial Radar · NCT07298395
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
105
Planned (sponsor's estimate)
Start
Dec 22, 2025
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Enveda TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Dec 23, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn about the safety and effectiveness of ENV-294 in adults with moderate to severe atopic dermatitis. The main questions it will answer are: * Is there an impact on the severity and area of atopic dermatitis when participants take ENV-294 * What medical problems do participants have when taking ENV-294 Participants will: * Take drug ENV-294 or a placebo once every day for 12 weeks * Visit the clinic every 2 to 4 weeks for checkups and tests * Keep a diary of their symptoms and when they took their study drug * Return to the clinic for the final study visit at approximately week 16
Conditions
- Atopic Dermatitis (AD)
Interventions
ENV-294Drug
ENV-294 is an orally administered investigational drug supplied as tablets. Participants receive ENV-294 once daily by mouth for 12 weeks.
PlaceboDrug
Matching oral tablet that does not contain active drug. Administered once daily by mouth for 12 weeks under the same conditions as the investigational product.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the efficacy of ENV-294 compared to placebo on severity and extent of atopic dermatitis (AD)Time frame: Baseline to Week 12
Locations
32 sites in 1 country. Site status is shown where the registry gives one.
Enveda Investigative Site
Birmingham, Alabama · Recruiting
Enveda Investigative Site
Hot Springs, Arkansas · Recruiting
Enveda Investigative Site
Beverly Hills, California · Recruiting
Enveda Investigative Site
Fremont, California · Recruiting
Enveda Investigative Site
San Diego, California · Recruiting
Enveda Investigative Site
San Diego, California · Recruiting
Enveda Investigative Site
Santa Monica, California · Recruiting
Enveda Investigative Site
West Hills, California · Recruiting
Enveda Investigative Site
Fort Lauderdale, Florida · Recruiting
Enveda Investigative Site
Miami, Florida · Recruiting
Enveda Investigative Site
Miramar, Florida · Recruiting
Enveda Investigative Site
Atlanta, Georgia · Recruiting
Enveda Investigative Site
Chicago, Illinois · Recruiting
Enveda Investigative Site
Clarksville, Indiana · Recruiting
Enveda Investigative Site
New Albany, Indiana · Recruiting
Enveda Investigative Site
West Lafayette, Indiana · Recruiting
Enveda Investigative Site
Louisville, Kentucky · Recruiting
Enveda Investigative Site
Louisville, Kentucky · Recruiting
Enveda Investigative Site
Auburn Hills, Michigan · Recruiting
Enveda Investigative Site
Bay City, Michigan · Recruiting
Enveda Investigative Site
Clinton Township, Michigan · Recruiting
Enveda Investigative Site
Warren, Michigan · Recruiting
Enveda Investigative Site
Las Vegas, Nevada · Recruiting
Enveda Investigative Site
New York, New York · Recruiting
Enveda Investigative Site
Wilmington, North Carolina · Recruiting
Enveda Investigative Site
Canton, Ohio · Recruiting
Enveda Investigative Site
Mayfield Heights, Ohio · Recruiting
Enveda Investigative Site
Camp Hill, Pennsylvania · Recruiting
Enveda Investigative Site
Arlington, Texas · Recruiting
Enveda Investigative Site
Houston, Texas · Recruiting
Enveda Investigative Site
San Antonio, Texas · Recruiting
Enveda Investigative Site
Norfolk, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.